Corsano Health

Corsano Health B.V. is a Dutch medical device company established in 2019 that develops clinical-grade wearable monitoring for hospital wards, remote patient monitoring programmes and pharmaceutical research. It targets the gap between consumer fitness trackers and bedside monitors, where general ward patients are usually checked only a few times a day.

The core product is the CardioWatch 287-2 bracelet, described by the company as the smallest and lightest patient bracelet available. It derives up to 19 vital parameters from PPG, ECG, bio-impedance, accelerometer, temperature and GSR sensing, including heart rate and RR intervals, SpO2, respiration rate, temperature, steps and gait metrics, streaming to companion iOS and Android applications and a monitoring platform. Firmware follows IEC 62304 and the quality system is validated under ISO 13485. Users are clinicians, hospital wards, researchers and pharmaceutical trial sponsors.

1. CardioWatch 287-2: CE-MDR Class IIa certified and FDA 510(k) cleared patient bracelet for continuous vitals.

2. Multi-sensor stack: PPG, ECG, bio-impedance, accelerometer, temperature and GSR yield up to 19 vital parameters.

3. Ward deployment: more than 100 general ward installations across Europe and South Africa.

4. Research use: more than 100 clinical trials and over 10,000 patients including paediatric and senior populations.

5. Reported outcomes: remote monitoring programmes report a 38% reduction in cost of care and a 70% reduction in readmissions.

6. Distribution: a distribution agreement with Medtronic extends its US acute care and monitoring wearables portfolio.